Biology of angiogenesis in tumors of the gastrointestinal tract

被引:80
作者
Reinmuth, N
Parikh, AA
Ahmad, SA
Liu, WB
Stoeltzing, O
Fan, F
Takeda, A
Akagi, M
Ellis, LM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
endothelial cells; VEGF; colon cancer; gastric cancer; pancreatic cancer;
D O I
10.1002/jemt.10258
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The realization that the growth and spread of tumors are dependent on angiogenesis has created new avenues of research designed to help us to better understand cancer biology and to facilitate the development of new therapeutic strategies. However, the process of angiogenesis consists of multiple, sequential, and interdependent steps with a myriad of positive and negative regulators of angiogenesis being involved. The survival of tumors and thus their metastases are dependent upon the balance of endogenous angiogenic and anti-angiogenic factors such that the outcome favors increased angiogenesis. Several growth factors have been identified that regulate angiogenesis in cancers of the gastrointestinal tract. These include pro-angiogenic factors like vascular endothelial growth factor (VEGF) and anti-angiogenic factors, i.e., thrombospondin. The following review provides a brief overview about the most important factors that are involved in the angiogenic process in tumors derived from colon, stomach, and pancreas. A thorough understanding of the role these factors play in the angiogenic process may lead to the development of novel therapeutic antineoplastic strategies. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:199 / 207
页数:9
相关论文
共 110 条
[1]  
Adachi Y, 2001, INT J CANCER, V95, P216, DOI 10.1002/1097-0215(20010720)95:4<216::AID-IJC1037>3.0.CO
[2]  
2-O
[3]  
Ahmad SA, 2001, CANCER, V92, P1138, DOI 10.1002/1097-0142(20010901)92:5<1138::AID-CNCR1431>3.0.CO
[4]  
2-L
[5]  
Ahmad SA, 2001, CANCER RES, V61, P1255
[6]  
Akagi Y, 1998, CANCER RES, V58, P4008
[7]   Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer [J].
Amaya, H ;
Tanigawa, N ;
Lu, C ;
Matsumura, M ;
Shimomatsuya, T ;
Horiuchi, T ;
Muraoka, R .
CANCER LETTERS, 1997, 119 (02) :227-235
[8]  
Araya M, 1997, J SURG ONCOL, V65, P232, DOI 10.1002/(SICI)1096-9098(199708)65:4<232::AID-JSO2>3.0.CO
[9]  
2-6
[10]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802